Bhubaneswar, Nov. 5 -- Bhubaneswar: In a remarkable finding on the lessons on the battle against COVID-19, a study conducted by the AIIMS Bhubaneswar has revealed that two-dose of anti-parasite drug Ivermectin reduced chances of the viral infection by a whopping 73%.

Bhubaneswar AIIMS Director Gitanjali Batmanabane said two-dose of Ivermectin prophylaxis within a gap of 72 hours was associated with 73 % reduction of COVID-19 infection among the healthcare workers (HCWs) of the hospital.

The study was conducted between September 20 and October 19 and its findings have given a new dimension to the ongoing research on the behaviour of SARS-CoV-2 and its treatment, said the authorities.

The exercise conducted by 12 physicians of AIIMS-BBSR...